REFERENCES
- Tehrani R, Ostrowski RA, Hariman R, Jay WM. Giant cell arteritis: oral versus intravenous corticosteroids. Neuro-Ophthalmology 2009;33:5–9
- Borg FA, Salter VL, Dasgupta B. Neuro-ophthalmic complications in giant cell arteritis. Curr Allergy Asthma Rep 2008;8:323–330.
- Ghanchi FD, Dutton GN. Current concepts in giant cell (temporal) arteritis. Surv Ophthalmol 1997;42:99–123.
- Hayreh SS, Podhajsky PA, Raman R, Zimmerman B. Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol 1997;123:285–296.
- Liozon E, Jauberteau-Marchan MO, Ly K et al. Giant cell arteritis with a low erythrocyte sedimentation rate: comments on the article by Salvarani and Hunder. Arthritis Rheum 2002;47:692–693.
- Hunder GG, Bloch DA, Michel BA et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122–1128.
- Coppeto JR, Monteiro M. Diagnosis of highly occult giant-cell arteritis by repeat temporal artery biopsies - some observations. Neuro-Ophthalmology 1990;10:217–218
- Hayreh SS. Ischaemic optic neuropathy. Indian J Ophthalmol 2000;48:171–194.